Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Nelson

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Urology|March 12, 1998
Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancerA A Baccala, H Zhong, S M Clift, et al.
The Journal of Urology|November 7, 2001
Plasma selenium level before diagnosis and the risk of prostate cancer developmentJ D Brooks, E J Metter, D W Chan, et al.
Cancer Research|February 24, 2001
Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1C P Nelson, L C Kidd, J Sauvageot, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 1998
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasiaJ D Brooks, M Weinstein, X Lin, et al.
Urology|April 11, 2001
Executive Summary of the National Cancer Institute Workshop: Highlights and recommendationsR Lieberman, W G Nelson, W A Sakr, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2000
No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective studyT F Shepard, E A Platz, P W Kantoff, et al.
Andrology|March 21, 2014
Racial variation in sex steroid hormone concentration in black and white men: a meta-analysisA Richard, S Rohrmann, L Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetateM A Carducci, J B Nelson, K M Chan-Tack, et al.
International Journal of Oncology|March 16, 2000
GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomasJ C Tchou, X Lin, D Freije, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1993
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damageT D Kessis, R J Slebos, W G Nelson, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Urology|March 12, 1998
Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancerA A Baccala, H Zhong, S M Clift, et al.
The Journal of Urology|November 7, 2001
Plasma selenium level before diagnosis and the risk of prostate cancer developmentJ D Brooks, E J Metter, D W Chan, et al.
Cancer Research|February 24, 2001
Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1C P Nelson, L C Kidd, J Sauvageot, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 1998
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasiaJ D Brooks, M Weinstein, X Lin, et al.
Urology|April 11, 2001
Executive Summary of the National Cancer Institute Workshop: Highlights and recommendationsR Lieberman, W G Nelson, W A Sakr, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2000
No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective studyT F Shepard, E A Platz, P W Kantoff, et al.
Andrology|March 21, 2014
Racial variation in sex steroid hormone concentration in black and white men: a meta-analysisA Richard, S Rohrmann, L Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetateM A Carducci, J B Nelson, K M Chan-Tack, et al.
International Journal of Oncology|March 16, 2000
GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomasJ C Tchou, X Lin, D Freije, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1993
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damageT D Kessis, R J Slebos, W G Nelson, et al.
Pageof 8